Cite

HARVARD Citation

    Soriano, L. et al. (n.d.). DGI-059 Safety of Anti-Epidermal Growth Factor Receptor Agents: Cetuximab and Panitumumab. European journal of hospital pharmacy. p. A117. [Online]. 
  
Back to record